procarbazine has been researched along with mitolactol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 7 (43.75) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casey, AE; Griswold, DP; Prejean, JD; Weisburger, EK; Weisburger, JH; Wood, HB | 1 |
| Kálmánchey, R; Koóos, R; Paraicz, E; Schuler, D; Somló, P | 1 |
| Borsi, J; Kardos, G; Koós, R; Paraicz, E; Révész, T; Schuler, D; Somló, P | 1 |
| Kardos, G; Révész, T; Schuler, D | 1 |
| Bertsch, L; Bouldin, TW; Cush, S; Krigman, MR; Mahaley, MS; Whaley, RA | 1 |
| Afra, D; Eckhardt, S; Kerpel-Fronius, S; Kocsis, B | 1 |
| Desser, RK; Ultmann, JE | 1 |
| Kálmánchey, R; Koós, R; Paraicz, E; Schuler, D; Somló, P | 1 |
| Davis, RL; Edwards, MS; Lamborn, K; Levin, VA; Prados, MD; Rabbitt, J | 1 |
| Dakhil, S; Hess, K; Jaeckle, KA; Kaba, SE; Kyritsis, AP; Levin, VA; Mercier, R; Yung, WK | 1 |
| Ater, J; Davis, R; Edwards, MS; Lamborn, K; Levin, VA; Prados, MD; Rabbit, J; Wara, W | 1 |
| De Witte, O; Hildebrand, J; Sahmoud, T | 1 |
| Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D | 1 |
| Davis, R; Edwards, M; Lamborn, K; Levin, VA; Malec, M; Prados, MD; Rabbitt, J; Wara, W | 1 |
| Afra, D; Sipos, L; Vitanovics, D | 1 |
| Banerjee, A; Berger, MS; Gupta, N; Haas-Kogan, DA; Lamborn, K; Mishra, KK; Prados, MD; Squire, S; Wara, WM | 1 |
1 review(s) available for procarbazine and mitolactol
| Article | Year |
|---|---|
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmustine; Chlorambucil; Cyclophosphamide; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukopenia; Mechlorethamine; Mitolactol; Nervous System Diseases; Procarbazine; Remission, Spontaneous; Streptonigrin; Vinblastine; Vincristine | 1973 |
8 trial(s) available for procarbazine and mitolactol
| Article | Year |
|---|---|
Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Hydroxyurea; Methylprednisolone; Middle Aged; Mitolactol; Procarbazine; Random Allocation; Teniposide; Tomography, X-Ray Computed | 1987 |
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Female; Glioma; Humans; Infant; Lomustine; Male; Mitolactol; Procarbazine; Thioguanine; Treatment Outcome; Vincristine | 1997 |
TPDC-FuHu chemotherapy for the treatment of recurrent metastatic brain tumors.
Topics: Adenocarcinoma; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Disease Progression; Female; Fluorouracil; Humans; Hydroxyurea; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitolactol; Procarbazine; Prospective Studies; Thioguanine | 1997 |
Response of recurrent glioblastoma and anaplastic astrocytoma to dibromodulcitol, BCNU and procarbazine--a phase-II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Female; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Mitolactol; Neoplasm Recurrence, Local; Procarbazine; Survival Analysis | 1998 |
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine | 1998 |
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Glioma; Humans; Lomustine; Male; Mitolactol; Procarbazine; Survival Analysis; Thioguanine; Treatment Outcome; Vincristine | 2000 |
[Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carmustine; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Glioblastoma; Humans; Male; Middle Aged; Mitolactol; Neoplasm Recurrence, Local; Procarbazine; Radiotherapy, Adjuvant; Reoperation; Supratentorial Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease Progression; Disease-Free Survival; Female; Glioma; Humans; Hypothalamic Neoplasms; Infant; Lomustine; Longitudinal Studies; Male; Mitolactol; Predictive Value of Tests; Procarbazine; Retrospective Studies; Salvage Therapy; Thioguanine; Treatment Outcome; Vincristine | 2010 |
7 other study(ies) available for procarbazine and mitolactol
| Article | Year |
|---|---|
The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinogens; Chlorambucil; Cyclophosphamide; Dacarbazine; Dactinomycin; Diethylnitrosamine; Female; Humans; Male; Melphalan; Mice; Mitobronitol; Mitolactol; Mitomycins; Neoplasms, Experimental; Nitrogen Mustard Compounds; Picolinic Acids; Procarbazine; Rats; Streptozocin; Uracil Mustard | 1975 |
Treatment of malignant scala posterior brain tumors in children: the chemotherapy of relapsed medulloblastoma with a dibromdulcitol containing drug regime and pharmacokinetic studies of dibromdulcitol in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Neoplasms; Child; Child, Preschool; Female; Humans; Male; Medulloblastoma; Mitolactol; Neoplasm Recurrence, Local; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Vincristine | 1992 |
New drug combination for the treatment of relapsed brain tumors in children.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Female; Humans; Infant; Male; Mitolactol; Neoplasm Recurrence, Local; Pilot Projects; Procarbazine; Vincristine | 1988 |
Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitolactol; Prednisone; Procarbazine; Radiography; Vincristine | 1988 |
Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Mitolactol; Procarbazine | 1986 |
The treatment of malignant scala posterior tumors in children: II. Preliminary result of the pre- and postoperative adjuvant chemotherapy of scala posterior tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Choroid Plexus Neoplasms; Ear Neoplasms; Ependymoma; Female; Humans; Infant; Male; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Vincristine | 1993 |
Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dose-Response Relationship, Radiation; Female; Follow-Up Studies; Humans; Infant; Male; Medulloblastoma; Middle Aged; Mitolactol; Neoplasm Staging; Neuroectodermal Tumors, Primitive; Nitrosourea Compounds; Procarbazine; Retrospective Studies; Risk Factors; Thioguanine; Vincristine | 1996 |